Mineralys Therapeutics, Inc. (NASDAQ:MLYS) has announced positive top-line data from two pivotal hypertension trials, Launch-HTN and Advance-HTN ... MLYS is one of the pump and dump stocks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results